Drug Profile
SJP 0139
Alternative Names: SJP0139Latest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator Senju Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for phase-I development in Unspecified(In volunteers) in Japan (PO)
- 13 Jan 2018 Phase-I clinical trials in Undefined indication (In volunteers) in Japan (PO) (UMIN000030621)